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Abstract
A molecular definition of the mechanism conferring bacterial multidrug resistance is clinically crucial and today methods for
quantitative determination of the uptake of antimicrobial agents with single cell resolution are missing. Using the naturally
occurring fluorescence of antibacterial agents after deep ultraviolet (DUV) excitation, we developed a method to non-
invasively monitor the quinolones uptake in single bacteria. Our approach is based on a DUV fluorescence microscope
coupled to a synchrotron beamline providing tuneable excitation from 200 to 600 nm. A full spectrum was acquired at each
pixel of the image, to study the DUV excited fluorescence emitted from quinolones within single bacteria. Measuring
spectra allowed us to separate the antibiotic fluorescence from the autofluorescence contribution. By performing
spectroscopic analysis, the quantification of the antibiotic signal was possible. To our knowledge, this is the first time that
the intracellular accumulation of a clinical antibitiotic could be determined and discussed in relation with the level of drug
susceptibility for a multiresistant strain. This method is especially important to follow the behavior of quinolone molecules
at individual cell level, to quantify the intracellular concentration of the antibiotic and develop new strategies to combat the
dissemination of MDR-bacteria. In addition, this original approach also indicates the heterogeneity of bacterial population
when the same strain is under environmental stress like antibiotic attack.
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Introduction
Since the use of antimicrobial agents to combat bacterial
infections, the emergence of bacteria that are resistant to
antibiotics was observed [1–8]. As a result, a large number of
infectious diseases, which had been reported to be controlled or
totally eradicated, are again in an upswing. Bacteria involved in re-
emerging infectious diseases increasingly withstand the action of
antibiotic clinical therapies by the dissemination of multi-drug
resistance (MDR) mechanisms [1–6]. The worldwide spreading of
MDR pathogens limits the treatment options and has become
a major cause of the therapeutic failures and mortalities in hospital
wards during recent decades. Obviously, MDR has became
a major health concern worldwide (for specific websites see: World
Health Organization: http://www.who.int/drugresistance/en/;
Center for Disease Control and Prevention: http://www.cdc.
gov/drugresistance/index.html; European Food Safety Authority:
http://www.efsa.europa.eu/en/topics/topic/amr.htm; European
Center for Disease Prevention and Control: http://www.ecdc.
europa.eu/en/healthtopics/antimicrobial resistance/Pages/in-
dex.aspx.
Extensive research has identified three major bacterial strategies
involved in the MDR development: (i) the target protection barrier
(alteration/modification of the target site); (ii) the enzymatic
barrier (degradation of the antibiotic molecule) and (iii) the
membrane barrier (acting to limit the required intracellular dose of
antibiotic) [9]. The drug resistance caused by the membrane
barrier, the first defence line in bacterial cells, is now recognized to
be a synergy between a reduced drug influx (due to lowering of
membrane permeability, e.g. by modification of porin activity [9])
and an active efflux of the drug (via efflux pumps that expel the
antibiotic out of the cell before it can reach its target site). As
consequence, the concentration of antibiotics within bacteria
decreases under the threshold required for its activity [9–14]. This
reduction can contribute to the development of additional
mechanisms of resistance including mutation of antibiotic targets
(e.g. in gyrase) or production of enzymes that cleave antibiotics (e.g.
ß-lactamases), and also reinforces the efficacy of these acquired
mechanisms [9,12,13]. In the face of this continuously emerging
threat, the development of efficient strategies to circumvent the
bacterial MDR responses depends upon understanding the
molecular basis of the mechanism controlling the intracellular
concentration of antibacterial agents.
A key point is the accurate determination of the antibiotic
concentration inside the targeted bacterium. Several experimental
approaches have been developed to reach this goal. Antibiotics
determination in biological samples has been performed by
radiometry [15–17], bioassays [18,19] and by UV absorbance
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liquid chromatography (HPLC) [20,21]. While bioassay tech-
niques are too laborious and generally inappropriate for kinetic
studies, the HPLC requires several manipulations such as
deprotonation and ion-pair extraction for sample preparations.
Moreover, UV absorption methods require higher concentrations
of antibiotics, since the UV detection is limited to concentrations
in the microgram/milliliter range. Radiometric assays are sensitive
and accurate, however they require drug radiolabeling, which
could impair biological activity of the molecule and requires an
internal standard. To overcome the limitations of existing
methods, the fluorimetric method has been proposed by Chapman
and Georgopapadakou [22]. The method is based on the natural
fluorescence of clinically used antibiotics, e.g., fluoroquinolones
such as ciprofloxacin or levofloxacin. A solubilization of bacteria
by lysate buffer is required prior to fluorescence detection of
antibiotics. Showing high sensitivity, rapidity and minimal sample
manipulation, the fluorimetric method is an attractive alternative
to the more invasive bioassay or less sensitive UV absorption assay.
However, the remaining problem associated with any of these
assays is that they detect antimicrobial agent in overall bacterial
masses, giving no specific information on antibiotic concentration
within any single cell. Knowledge about the intracellular
concentration and antibiotic location inside the bacterium is
essential to define the complete molecular mechanism and the
possible ways for tackling antibiotic resistance.
Here we report the quantitative single-cell fluorescence micro-
scopic study of Enterobacter aerogenes resistant strains using a new
non-invasive method preserving the antibiotic structure which
have allowed us to monitor the antibiotic uptake depending on the
efflux pump activity. Considering the natural fluorescence of
clinically used quinolone, we use synchrotron radiation DUV
imaging and the synchrotron radiation DUV microspectroscopy as
new methods to investigate the drug accumulation inside
individual bacteria. Two fluorescence microscopes were used: for
DUV imaging we used a DUV compatible full-field microscope,
whereas the DUV microspectroscopy was achieved by using the
microscope, which allows collecting the fluorescence spectra.
Fleroxacin (Fle) was chosen as target quinolone to test the concept
in vitro. Since the fluorimetric method of Fle uptake on digested
bacterial masses has been previously validated [22,23], we used
this method as our internal standard. The intrabacterial concen-
tration has been studied in two bacterial strains of Enterobacter
aerogenes: a resistant isolate EA289 that overproduced the broad
spectrum AcrAB-TolC efflux pump, and the tolC deficient
derivative strain EA298 [24]. The activity of efflux pump on
antibiotic uptake has been assessed using co-incubation with
glucose (Glu) as well as carbonyl cyanide m-chlorophenyl
hydrazone (CCCP). CCCP is a powerful uncoupler of the proton
motive force (PMF) that collapses the membrane energy,
consequently, used at low concentrations, it inhibits the drug
transport through the inner membrane. Belonging to the group of
efflux pump blockers/modulators, it is used for a long time to
study the antibiotic expel by Gram-negative efflux pumps (for
recent reviews see [25,26]). These results have important
implications for the understanding of intracellular accumulation
of quinolones in single multidrug resistant clinical bacteria and to
develop original ways to combat resistance mechanisms associated
with membrane permeability.
Results
To investigate the mechanism that controls the intracellular
concentration of antibiotics in single resistant isolate and to define
the ways to increase normal concentration, we have selected a tri-
fluoroquinolone, flerofloxacin (fleroxacin, Fle) and an E. aerogenes
resistant strain from a MDR isolate which overexpresses the broad
spectrum AcrAB-TolC efflux pump and its efflux derivative (tolC
-).
Glucose (Glu) and carbonyl cyanide m-chlorophenyl hydrazone
(CCCP) are used to respectively energize and collapse the active
efflux transport. The incubation time was selected from the
previous experiments carried out on this resistant isolate with
radiolabelled norfloxacin indicating that the steady-state level of
fluoroquinolone accumulation was observed at about 10 min
incubation [27].
Antibiotics Concentration Measured by Fluorimetric
Assay on Bacterial Lysates
The dependence of Fle fluorescence as a function of bacteria co-
incubation (+CCCP, +Glu or in the absence of additives) is
presented in Fig. 1A. Incubation of the bacterial suspension with
CCCP increased the Fle uptake by bacterial cells, i.e. a higher
fluorescence intensity of Fle was detected, when compared with
the incubation carried out with antibiotic alone. In contrast, no
significant difference in Fle fluorescence was observed during co-
incubation with or without Glu. Note, the maximum of
fluorescence spectra emission from Fig. 1A corresponds to the
emission of Fle fluorescence previously identified in lysate buffer
(Gly-HCl, pH=3) (Fig. S1).
For each condition, the Fle fluorescence intensity was connected
with its concentration based on calibration curve. The concentra-
tion of Fle uptake by bacteria is presented in Fig. 1B. Starting
with Fle concentration of 1mg/ml, which represents the detection
limit of this fluorimetric assay (Fig. 1B), the intracellular drug
concentration increases, with higher Fle concentrations. This
trend was observed for resistant as well as sensitive strains of
E. aerogenes. Furthermore, in the absence of Glu or CCCP, for each
concentration of Fle incubation, the intracellular Fle concentration
was higher in EA298 (sensitive) than in EA289 (resistant). This fits
well with Fle-MIC measured for the two strains (Table 1). The
effect of CCCP, added as uncoupler of membrane energy during
antibiotic incubation, boosted intracellular concentration of Fle
(Fig. 1B). This increase was more important in efflux-producer
strain EA289. The similar results to those for Fle have been
observed also for another clinically relevant quinolone, ciproflox-
acin (Cip). Cip accumulation was more pronounced in EA298
than in EA289. Cip concentration was similarly increased in the
presence of CCCP for both strains (more pronounced for EA289
than for EA298) and the Glu effect varied between Cip
concentrations and bacteria strains (Fig. S2).
Single Cell DUV Fluorescence Microspectroscopy and
Imaging
In order to determine experimental conditions to detect Fle
fluorescence in bacteria, spectral characteristics of Fle were
analysed. The fluorescence emission and excitation spectra of
Fle in PBS, pH=7 are presented in Fig. 2A. In this buffer, Fle
exhibits a maximum of fluorescence emission at a wavelength,
lemis, of 421 nm and a maximum of excitation at a wavelength,
lexc, of 275 nm. To assess the optimal excitation wavelength for
fluorescence detection of Fle, we had to carefully consider the
contribution of natural fluorophores present in bacteria, notably
tyrosine, tryptophan and NADH molecules. Bacterial natural
fluorophores could exhibit fluorescence intensities orders of
magnitude greater than those from the weakly fluorescence
antibiotics. Excitation at lexc=290 nm revealed to be the best
for the Fle detection in living bacteria. The fluorescence emission
Fluoroquinolone Uptake in Single Bacterial Cell
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However, as presented on Fig. 2A, this covers only half of the
Fle fluorescence. This energy band pass was selected maximise the
contribution of Fle relative to the autofluorescence of tryptophan,
the main contributor to the overall autofluorescence signal.
Because microscopy technique deals with single bacteria the
concentration of Fle was adjusted to 64 mg/ml. Figs. 2B–2C
present transmission and fluorescence images of EA289 strain
obtained in Fle-treated bacteria (at 64 mg. ml
21 concentration)
without additives (Fig. 2B) and in the presence of CCCP
(Fig. 2C), after subtraction of the autofluorescence contribution.
No fluorescence was detected from Fle-treated bacteria (Fig. 2B).
This is in contrast to Fle-treated bacteria co-incubated with CCCP
(Fig. 2C) where a high signal was detected. We attribute this to
a marked increase of intracellular Fle fluorescence. In addition,
from the merge image of the transmission and fluorescence images
in Fig. 2C, it can be noted that some individual bacteria were not
fluorescent even in the presence of proton uncoupler. Figure 2D
shows the quantitative distribution of Fle fluorescence from single
bacteria presented on Figure 2C. Signal variations from single
cells (Fig. 2D) indicates that inside a bacterial population, issue
from a same controlled strain inoculum, different level of resistant
phenotypes may co-exist controlling the antibiotic accumulation,
as recently reported by Lee and co-workers under external stress
[28] (for a review see [29]).
In Fig. 2E, the fluorescence intensities of the 420–480 nm
wavelength range from EA289 bacteria strain incubated with and
without Fle in presence of Glu and CCCP are presented. While
Glu induced increase in bacterial autofluorescence when
compared with un-treated bacteria, the signal co-incubated with
CCCP was lower. Considering Glu as energizer, whereas CCCP
as proton uncoupler [4,30], it is not surprising that the optical
properties of bacteria changed as a result of metabolic activity
modification. The sensitivity of DUV microscopy for changes in
the signal can be seen also for Fle. Results from Fig. 2E suggest
that the measurement of Fle accumulation with DUV micros-
copy must be corrected by the bacterial autofluorescence
contribution and the variation between the different induced
autofluorescences due to incubation conditions. Only Fle-CCCP-
treated bacteria (in Fig. 2E, noted the difference F-E)
demonstrated significantly higher intensity in 420–480 nm
wavelength range when compared to control conditions (in
Fig. 2E, noted the difference B–A or D–C).
DUV Microspectrofluorimetry
Spectra recorded from single Fle-untreated bacteria (indicated
in Fig. 3A) with lexc=290 nm are presented in Fig. 3B. The
peak around lemis=340 nm corresponds to the tryptophan
fluorescence, an aromatic amino-acid, component of proteins
[31–33]. The comparison of those spectra shows differences in
inter-bacterial auto-fluorescence intensity (Fig. 3B). To correct for
those differences, spectra from individual bacteria from different
locations were averaged and then normalized on the tryptophan
peak.
Figure 1. Fleroxacin uptake by Enterobacter aerogenes popula-
tion. A. Fluorescence emission spectra of Fle (lexc=283 nm) detected
from Glycin-HCl-induced lysis of Enterobacter aerogenes strain EA289.
EA289 were incubated with Fle (2 mg/ml) for 30 min in follow
conditions: (2? 2? ) Fle; (222) Fle + Glu (0.4%); (–) Fle + CCCP
(10 mM). B. Comparison of Fle concentration uptake determined from
lysated bacteria. Enterobacter aerogenes strains EA289 and EA298 were
incubated with Fle at different concentrations (1, 2 or 8 mg/ml) alone or
with Glu (0.4%) or CCCP (10 mM).
doi:10.1371/journal.pone.0038624.g001
Table 1. Major characteristics of bacterial strains and MIC values for fluoroquinolones.
Bacterial strains Characteristics MIC (mg.ml
21)
Enterobacter aerogenes Fle Cip
EA289 Kan
s derivate of EA27 (MDR clinical isolate) 128 32
EA298 EAEP289 tolC
- :Kan
r 32 4
Fle, fleroxacin; Cip, ciprofloxacin.
doi:10.1371/journal.pone.0038624.t001
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presented as Supplementary information (Figs. S3A–C). Fle
increased the fluorescence recorded between 400 and 450 nm.
Subtraction of control spectra revealed Fle fluorescence emission
spectra (Fig. 4). The peak position of fluorescence emission of Fle
fits well with Fle fluorescence in PBS buffer at pH=7 (Fig. 2A)
Figure 2. Fleroxacin uptake by individual Enterobacter aerogenes.A . Fluorescence spectra of Fle (750 ng/ml) in PBS pH=7: (222) excitation
spectrum at lemis=420 nm; (–) emission spectrum at lexc=313 nm. B. Transmission (left), fluorescence (middle) and merge (right) images of Fle
(64 mg/ml)-treated EA289 bacteria. Scale bar corresponds to 3 mm. C. Transmission (left), fluorescence (middle) and merge (right) images of Fle
(64 mg/ml)- and CCCP- (25 mM) treated EA289 bacteria. Scale bar corresponds to 3 mm. D. Percentage of maximum fluorescence intensity of Fle
within single bacteria from fig. 2C. E. Fluorescence intensity detected from Fle channel (lexc=290 nm; DM 300 nm; BP filter 420# lemis #480 nm)
from individual EA289 bacteria as a function of treatment conditions: (a) EA289 with no additions; (b) EA289 incubated with Fle (64 mg/ml); (c) EA289
incubated with Glu; (d) EA289 co-incubated with Glu and Fle (64 mg/ml); (e) EA289 incubated with CCCP (25 mM); (f) EA289 co-incubated with CCCP
(25 mM) and Fle (64 mg/ml).
doi:10.1371/journal.pone.0038624.g002
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modified in bacteria.
Analyses of the Fle fluorescence obtained from different
locations of bacteria showed a decrease within Glu-treated
bacterial samples, while the co-incubation with CCCP demon-
strated significantly higher fluorescence than with Fle alone
(Fig. 5A). Similar variations in Fle uptake demonstrated by
extraction method are presented on Fig. 5B.
By using radiolabelled norfloxacin to investigate the intracellu-
lar drug concentration in a different E. aerogenes resistant clinical
isolate, Chevalier et al had reported a rough increase of
fluoroquinolone when the incubation was carried out in the
Figure 3. Individual bacteria microspectro-fluorescence measurement. A. Transmission image of Enterobacter aerogenes EA289 bacteria.
White arrow indicates on bacterium from which one of the fluorescence spectra of fig. 3B was taken. Scale bar corresponds to 3 mm. B. Fluorescence
emission spectra (recorded by UV-VIS microspectrofluorimetry at lexc=290 nm) from two individual Fle-untreated bacteria EA289. Fluorescence
emission spectrum (2? 2? ) corresponds to bacterium marked on fig. 3A; (–) spectrum corresponds to bacterium not in the field of view.
doi:10.1371/journal.pone.0038624.g003
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treated/non-treated bacteria being 2.3 [34]. It must be noted that
during this previous determination, no internal control was used to
standardize the assays and no test was carried out with Glu
addition.
Discussion
With the continuing emergence of MDR bacteria, methods
have been developed to follow the uptake of antibiotics in bacteria,
but none is presently able to quantify the quinolones uptake in
single bacteria. Indeed, the knowledge about the intracellular
concentration of antibiotics and their accumulation inside the
bacterial cell is a key point to molecularly dissect the resistance
mechanism and develop possible ways for tackling MDR bacteria.
In addition, it is now recognized that small internal concentrations
of drugs, under the threshold necessary to kills bacteria, are able to
induce the accumulation of internal metabolites (signals) that
triggers the bacterial response and activate genetic cascade of
resistance mechanisms [9,23,28,30].
For these reasons, it is now urgently required to develop the
concept of quinolones detection in single bacteria using the DUV
fluorescence microspectroscopy and imaging. This new method is
validated by detection of quinolone molecule Fle for which an
extraction measurement was derived from a previously established
protocol [22,23]. In addition, to assess a direct measurement of
efflux pump activity and correlation with Fle bacterial suscepti-
bility, the differences in Fle uptake within an E. aerogenes isolate that
overproduces efflux pump, EA289, and an efflux-derivative strain,
EA298, were investigated.
A higher antibiotic uptake was determined in the tolC derivative
EA298, when compared with the parental strain EA289 that over-
expresses AcrAB-TolC efflux pump. To distinguish whether this is
due to the activity of efflux pump in the latter strain, the
measurement was carried out with CCCP, an uncoupler known to
collapse the membrane energy and block the energy-dependent
efflux pump [35–37]. A substantial increase in the Fle uptake by
EA289 in the presence of CCCP clearly illustrates the contribution
of efflux pump on the drug concentration. Furthermore, this
accumulation was higher than when EA298 were incubated in
absence of the efflux pump inhibitor. Our observations with
another clinically relevant quinolone, ciprofloxacin (Cip) (Fig. S2)
are in concordance; Cip accumulation was more pronounced in
EA298 than in EA289. Cip concentration was similarly increased
in the presence of CCCP for both strains (more pronounced for
EA289 than for EA298) and the Glu effect varied between Cip
concentrations and bacteria strains.
The fluorescence detection by DUV imaging was focused on
EA289 bacteria for which the gain of the intracellular concentra-
tion of Fle in the presence of CCCP was more prominent. In
addition, the Fle concentration of 64 mg/ml was selected to allow
Figure 4. Fluorescence intensity of Fleroxacin from Enterobacter
aerogenes bacteria. Mean fluorescence emission spectra
(lexc=290 nm) of Fle from Enterobacter aerogenes EA289 bacteria were
measured by UV-VIS microspectrofluorimetry. Fle (64 mg/ml)-treated
bacteria were co-incubated with follow additives: (–) CCCP (25 mM);
(222) Glu (0.4%) and (2? 2? ) in the additives absence (EA289
incubated only with Fle).
doi:10.1371/journal.pone.0038624.g004
Figure 5. Comparison of fluorescence intensity and concentra-
tion of Fleroxacin in individual bacteria and lysated bacteria.
A. Fluorescence intensity of Fle measured by UV-VIS microspectro-
fluorimetry from individual EA289 bacteria. EA289 were incubated with
Fle (64 mg/ml) only or with Glu (0.4%) or CCCP (25 mM). B. Comparison
of Fle concentration uptake determined from lysated bacteria.
Enterobacter aerogenes EA289 were incubated with Fle (64 mg/ml)
alone or with Glu (0.4%) or CCCP (25 mM).
doi:10.1371/journal.pone.0038624.g005
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fluorescence microscopes, respecting their minimum fluorescence
detection limits (i.e.,6 4 mg/ml in DUV analysis compared to
1 mg/ml in fluorimetric detection within a bacterial lysate).
Indeed, while 10
9 cells/ml contributed to fluorescence which is
detected from bacteria lysate, only one cell contributed to
fluorescence detected by imaging system.
To assess the Fle uptake in individual bacteria we used two
DUV fluorescence microscopes: the first microscope collects
fluorescence spectra of microvolumes, and the second, full-field
microscope gives the global fluorescence intensity in a defined
spectral range (420–480 nm in this study). We would like to
emphasize that the eligibility of an antibiotic for synchrotron-
radiation UV fluorescence microspectroscopic studies depends
upon production of post-excitation fluorescence between 200 and
400 nm, associated with a minimal interference due to bacterial
autofluorescence emission spectra. The second condition is
difficult to achieve since antibiotics exhibit small Stoke’s shift
and because several natural occurring fluorochromes exhibit
absorption in the UV and DUV region [33,37]. To minimize the
contribution from the autofluorescence signal, we had to
carefully consider the absorption and fluorescence properties of
natural fluorophores present in bacteria, notably tyrosine,
tryptophan and NADH. In our study, the selected excitation
wavelength lexc=290 nm was the best for obtaining a high Fle/
autofluorescence ratio. This wavelength corresponds to a mini-
mum of absorption for bacterial autofluorophores [33] and
justifies our observation of highest Fle/autofluorescence contrast.
In addition, in order to reduce the contribution of autofluores-
cence, the fluorescence of Fle was analyzed in the 420–480 nm
spectral range. For the first time, detection of Fle inside single
bacteria was possible. It is important to note that the Fle
detection is impaired by autofluorescence contribution that
changes with the incubation conditions. This has important
consequences for the general interpretation of fluorescence
measurements. The autofluorescence contribution plus its corre-
lation with physiological processes in bacteria are making the
quantitative approach of Fle fluorescence difficult. A method
correcting for the influence of autofluorescence effects, would be
a step forward.
We used synchrotron-radiation DUV microspectroscopy as
a method to accurately quantify the antibiotic fluorescence in
single bacteria. Measuring the spectra from single bacteria allowed
monitoring of antibiotic fluorescence together with autofluores-
cence contribution. By doing spectroscopic analysis, the auto-
fluorescence was successfully subtracted and consequently, the
quantification of the signal from different conditions of co-
incubations was possible.
The comparison of the antibiotic fluorescence measured on
single bacteria with the levels obtained from bacteria lysates
yielded strong evidence that the concentration uptake of anti-
biotics (Fle and Cip) was heavily increased by CCCP addition.
This proves that synchrotron-radiation UV fluorescence micro-
spectroscopy can be used as a method to evidence the antibiotic
intra-bacterial accumulation and thus directly monitor the efflux
pump activity and the antibiotic susceptibility correlation.
In addition, we clearly demonstrated that the fluorescence drug
signal from individual bacteria varied, within in a uniformly
treated population. Considering that measurements are done on
single bacteria, our technique can be further developed and
applied to probing a bacterial population, and generate statistical
information about individual bacterial uptake since isogenic
microbial populations contain substantial cell-to-cell differences
in physiological parameters such as growth rate, resistance to stress
and regulatory circuit output (for a review see [29]). Regarding this
point, it is important to mention that Long et al [38] recently
reported that the quantification by single-cell fluorescence
microscopy of bacterial signalling responses to AI-1 and AI-2
autoinducers involved in quorum sensing regulation, indicates
a coherent response across the population but some cell-to-cell
variations. This is especially important taking into account the
bacterial adaptability to external stresses and antibiotic attacks and
reflects the recent observation about the bacterial charity [28]. In
addition, this result correlates with the large and rapid change
involving the expression of transporters in bacterial membrane
faced with external antibacterial agents (including antibiotics,
biocides, etc). This efficient alteration of transporters expression
rapidly modifies the membrane permeability and the associated-
drug uptake [39,40]. This original approach indicates the
heterogeneity of bacterial population regarding the antibiotic
accumulation and may provide appropriate clues to understand
the role of ciprofloxacin in the bacterial adaptation and persister
formation as recently reported by Do ¨rr et al [41].
To our knowledge, this is the first time that an antibiotic under
its natural clinical form (e.g. without artificial labelling) has been
monitored within single bacterial cells. This is a matter of
importance taking into account recent publication reporting that
low antibiotic concentration are able to select and maintain
resistance mechanisms in bacterial population and several
mathematical models analysing antibiotic combinations to treat
resistant bacteria [42,43]. This places synchrotron-radiation UV
fluorescence microspectroscopy in an ideal position to quantify the
uptake of non-modified clinical antimicrobial agents in bacteria,
and open a new field of research in antibacterial chemotherapy.
This first study represents an important milestone for un-
derstanding and combating the drug resistance mechanism in
MDR bacteria. Important questions remain to be addressed in
subsequent studies. It will be extremely valuable to determine the
location of antibiotics during their uptake inside bacterial cells, in
membrane, in periplasmic space or in cytoplasmic space, and how
the inhibition of drug transporters changes this location. In
addition, it will be important to determine the concentration and
location of antibiotic molecules targeting the bacterial membrane.
Materials and Methods
Bacterial Strains and Growth Conditions
Strains used in this study are listed in Table 1. Experiments
were carried out on two E. aerogenes strains previously described
[24]: EA289, a clinical multi-drug resistant strain that over-
expresses AcrAB-tolC efflux pumps, and EA298, its tolC
- de-
rivative. Strains were routinely grown at 37uC on Luria-Bertani
(LB) agar or in LB broth, supplemented with kanamycine
(50 mg.ml
21) for EA298.
Antibiotics Accumulation
Bacteria grown in its exponential-phase (corresponding to 0.6
optical density units at 600 nm) were concentrated 10 fold. Briefly,
the bacterial suspension was centrifuged at 6 000 g for 15 min at
20uC and pellets were resuspended in 1/10 of the volume in
a sodium phosphate buffer (50 mM) at pH 7 supplemented with
MgCl2 (NaPi-MgCl2 buffer) to obtain a density of 10
10 CFU.ml
21.
Bacteria suspension (1.6 ml) was incubated 30 min at 37uC (final
volume 2 ml) with different concentration of antibiotics, Fle or Cip
(1, 2, 4, 8 or 64 mg.ml
21) in the absence or in the presence of
CCCP (10 mMo r2 5mM) or Glu (0.4%) respectively. Bacterial
suspensions incubated without antibiotics, with CCCP or with Glu
were used as controls. Suspensions (800 ml or 400 ml) were then
Fluoroquinolone Uptake in Single Bacterial Cell
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and centrifuged at 13 000 rpm for 5 min at 4uC to eliminate
extracellular-adsorbed fluoroquinolones and collect washed bac-
teria.
To follow the Fle uptake by EA289 and EA298 strains, we used
the routine fluorimetric method previously described by Chapman
et al. [22]. Briefly, pellets corresponding to 800 ml of suspensions
were solubilized with 500 ml of 0.1 M Glycin-HCl pH3 buffer at
least 2 h at room temperature. After a centrifugation for 10 min at
13 000 rpm, 400 ml of lysates were diluted in 600 ml of 0.1 M
Glycin-HCl pH3 buffer and analysed by spectrofluorimetry.
To detect the antibiotics fluorescence from single bacteria,
pellets corresponding to 400 ml of suspensions were resuspended in
200 ml of NaPi-MgCl2 buffer and analysed by DUV microspec-
trofluorimetry or DUV fluorescence imaging.
Spectrofluorimetry Analysis
The fluorescence spectra of bacteria lysates were recorded at
20uC using a FluroMax-4 (HORIBA Jobin Yvon INC, Chilly
Mazarin, France) spectrofluorimeter. The quartz cuvette of 1 cm
pathlength was used for measurement. Fluorescence emission
spectra of lysate were recorded at an excitation wavelength of
283 nm. This wavelength was previously determined to be suitable
for Fle detection (e.g. in 0.1 M buffer of Glycin-HCl of pH=3, Fle
exhibits its maximum of excitation at 283 nm and emission at
451 nm (Fig. S1)). To quantify the Fle fluorescence intensity in
bacteria lysate, spectra were normalized using the tryptophan peak
at 356 nm (Fig. S4) and subtraction of spectra representing
control samples (no drug, Glu or CCCP only) was proceed. Fle
concentrations in bacteria lysate were calculated according to
a calibration curve generated by mixing a known concentration of
Fle with Glycin-HCl of pH=3.
DUV Microspectrofluorimetry
Fluorescence spectra from individual bacteria were recorded on
a deep ultraviolet (DUV) microspectrofluorimeter at Synchrotron
SOLEIL [31]. Briefly, the 290 nm excitation of a bending magnet
from DISCO beamline [44] was focalised on bacteria deposited
with their medium (0.5 ml of resuspended pellets) on quartz
coverslips. The objective used was Zeiss ultrafar immersed
objective with 1006 magnification. Emission spectra were
recorded with the acquisition time of 90 s and have been
measured on 5 different localisations, i.e. 5 different bacteria.
Individual spectra recorded in the same condition from bacteria
on different localisations were smoothed and averaged by Microcal
Origin, version 8.0 program (Microcal Software, Inc., North-
ampton; MA). To compare the region of antibiotic fluorescence,
spectra were brought on the same baseline level and normalized
on the peak of tryptophan at 340 nm (Fig. S3).
DUV Fluorescence Imaging
Bacteria strains were observed in brightfield and excitated in
DUV with a Zeiss Axioobserver Z21. The selected objective was
a 1006 Zeiss ultrafluar objective needing glycerine immersion.
The Fle fluorescence was recorded by excitation at 290 nm, using
the dichroic mirror of 300 nm (OMEGA Optical, Inc., USA) and
emission bandpass filter for 420–480 nm wavelengths (OMEGA
Optical, Inc., USA). To detect fluorescence images, we used CCD
camera from Hamamatsu C9100-13 (HAMAMATSU PHO-
TONICS France SARL, France). The integration time of camera
was 2 min for applied excitation and filter combination used to
visualize the Fle fluorescence. In addition, to increase the signal to
noise ratio, images were recorded with binning of the pixel (262)
in Micro-Manager program [45], used to manipulate the CCD
camera.
The image analyses were performed with Image J (Rasband,
W.S., ImageJ, U. S. National Institutes of Health, Bethesda,
Maryland, USA, http://imagej.nih.gov/ij/, 1997–2011). Illumi-
nation being in-homogeneous, it was corrected before background
subtraction. First, threshold was automatically adjusted using
a triangle algorithm; thereafter, bacteria were analysed as the
remaining particles. The mean intensity coming from each
bacterium was automatically calculated considering its pixel area.
Finally, all bacteria signal taken from one image were averaged.
For each condition, two different localisations with minimum 30
bacteria per plane were recorded and averaged. Resulting
fluorescences were analysed using Microcal Origin 8 (Microcal
Software Inc, Northampton, MA).
In order to present images of bacteria with fluorescence signal
from Fle, the contribution of autofluorescence to the instinct
fluorescence of bacteria was measured from Fle-untreated bacteria
with follow subtraction from Fle-treated bacteria (e.g. bacteria
incubated with Fle in CCCP absence and/or presence). The same
contrast was chosen for all images for better visual comparison.
Supporting Information
Figure S1 Fluorescence spectra of Fle (50 ng/ml) in
Glycin–HCl pH=3. (222) excitation spectrum at le-
mis=451 nm; (–) emission spectrum at lexc=283 nm.
(TIFF)
Figure S2 Comparison of Ciprofloxacin concentration
uptake determined from lysated bacteria. Enterobacter
aerogenes strains EA289 and EA298 were incubated with Cip (1, 2
or 4 mg/ml) alone or with Glu (0.4%) or CCCP (10 mM).
(TIFF)
Figure S3 Fluorescence spectra of Fleroxacin from
individual bacteria incubated with different additives.
A.Mean fluorescence emission spectra (lexc=290 nm) of control
(–) and Fle-treated (–) Enterobacter aerogenes EA289 bacteria
measured individually by UV-VIS microspectrofluorimetry.
B.Mean fluorescence emission spectra (lexc=290 nm) of control
(–) and Fle-Glu-treated (–) Enterobacter aerogenes EA289
measured individually by UV-VIS microspectrofluorimetry.
C.Mean fluorescence emission spectra (lexc=290 nm) of control
(–) and Fle-CCCP-treated (–) Enterobacter aerogenes EA289
measured individually by UV-VIS microspectrofluorimetry.
(TIFF)
Figure S4 Fluorescence emission spectra (lexc=283 nm)
of Enterobacter aerogenes strain EA289 bacteria lysate.
Bacteria were incubated with or without Fle (2 mg/ml) in follow
conditions: (222, red) no additions; (2??2??, red) with CCCP
(10 mM); (222, blue) with Fle and Glu (0.4%); (–, blue) with Fle;
(2??2??, black) with Fle and CCCP (10 mM). Bacteria incubated
with Glu demonstrates the identical spectra features as bacteria
with no additions, e.g. (222, red).
(TIFF)
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